PMC:3656366 / 8076-8899 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/3656366","sourcedb":"PMC","sourceid":"3656366","source_url":"http://www.ncbi.nlm.nih.gov/pmc/3656366","text":"Drug Treatments\nReboxetine (40 mg/kg per day; Ochem, Chicago, IL), desipramine (30 mg/kg per day; Sigma-Aldrich, Vienna, Austria), fluoxetine (18 mg/kg per day; Eubio, Vienna, Austria), paroxetine (10 mg/kg per day; Ochem), and citalopram (10 mg/kg per day, kindly provided by Lundbeck, Denmark) were administered via the drinking water for 3 weeks. A drug intake of the dose indicated above was achieved by adapting the concentrations of the drug in the drinking solutions according to mean drinking volume and body weight per cage (Sartori et al, 2012). Mice were kept on drug treatment until completion of all experiments. Control mice received tap water. 5-Bromo-2′-deoxyuridine (BrdU) (Sigma-Aldrich) was injected at a dose of 100 mg/kg (intraperitoneally) once per day for 4 days for the labeling of newly born cells.","divisions":[{"label":"Title","span":{"begin":0,"end":15}}],"tracks":[{"project":"2_test","denotations":[{"id":"23325324-21835188-76171885","span":{"begin":549,"end":553},"obj":"21835188"}],"attributes":[{"subj":"23325324-21835188-76171885","pred":"source","obj":"2_test"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"2_test","color":"#93acec","default":true}]}]}}